Trial Profile
A Single Dose, Crossover Study in Healthy Female Subjects to Assess the Regional Absorption and Bioavailability of 100 mg GSK2190915A.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Oct 2023
Price :
$35
*
At a glance
- Drugs Fiboflapon (Primary) ; Fiboflapon (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors GSK
- 26 Mar 2011 New trial record
- 25 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.